ANXA5 and cancer: Next, we directly compared the ability of the NK cells to reduce OVCAR-3 and SKOV-3 viability by quantifying the live (7AAD− Annexin V APC−) cells and normalising against the cancer cells alone to allow for direct comparison between OVCAR-3 and SKOV-3 cells (Fig. 3).